Wendy Erler

Wendy Erler is an accomplished healthcare executive with extensive experience in patient advocacy, experience, and insights, currently serving as VP Global Head Patient Experience at AstraZeneca and VP Global Head Patient Experience at Alexion Pharmaceuticals, Inc. Since 2020, Wendy has contributed as a board member for both the Huntington's Disease Society of America and RARE-X. Prior roles include VP Patient Advocacy and Commercial at Wave Life Sciences, where responsibilities encompassed global patient advocacy and market insights for rare genetic diseases, and significant leadership positions at Biogen, Shire, and GlaxoSmithKline. Wendy holds a Bachelor of Arts in Communications/Marketing from Miami University and an MBA in Marketing from Saint Joseph's University.